Valproic acid, congenital malformation risk advance, and relation of the 13th pregnancy half year
Source on June 14, 2010: NEJM (thesis list) category: Nerve internal disease (related paper) - obstetrics and gynecology trouble (related paper) and - problem (related paper) document related to administering: Jentink J et al. Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. NEJM. 2010;362:2185-2193
The relation to the congenital malformation of 14 specified from the valproic acid use and eight cohort studies at the 13th pregnancy half year is discussed by the case contrast research by using the data base of the antiepileptic research of Europe. A significant relation was seen about congenital malformations (spina bifida, atrial septal defect, uvula bifida, hypospadia, polydactyly, and craniosynostosis)14 inside 6 in the valproic acid monotherapy and the risk advance.
Japan is good country!
http://japan-power.net/
PLEASE come here!
Source on June 14, 2010: NEJM (thesis list) category: Nerve internal disease (related paper) - obstetrics and gynecology trouble (related paper) and - problem (related paper) document related to administering: Jentink J et al. Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. NEJM. 2010;362:2185-2193
The relation to the congenital malformation of 14 specified from the valproic acid use and eight cohort studies at the 13th pregnancy half year is discussed by the case contrast research by using the data base of the antiepileptic research of Europe. A significant relation was seen about congenital malformations (spina bifida, atrial septal defect, uvula bifida, hypospadia, polydactyly, and craniosynostosis)14 inside 6 in the valproic acid monotherapy and the risk advance.
Japan is good country!
http://japan-power.net/
PLEASE come here!
コメントする